IL83579A0 - Rapid acting combination of sulindac or sodium sulindac and a base - Google Patents

Rapid acting combination of sulindac or sodium sulindac and a base

Info

Publication number
IL83579A0
IL83579A0 IL83579A IL8357987A IL83579A0 IL 83579 A0 IL83579 A0 IL 83579A0 IL 83579 A IL83579 A IL 83579A IL 8357987 A IL8357987 A IL 8357987A IL 83579 A0 IL83579 A0 IL 83579A0
Authority
IL
Israel
Prior art keywords
sulindac
base
sodium
rapid acting
acting combination
Prior art date
Application number
IL83579A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL83579A0 publication Critical patent/IL83579A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
IL83579A 1986-08-25 1987-08-18 Rapid acting combination of sulindac or sodium sulindac and a base IL83579A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/900,201 US4704405A (en) 1986-08-25 1986-08-25 Rapid acting combination of sodium sulindac and a base

Publications (1)

Publication Number Publication Date
IL83579A0 true IL83579A0 (en) 1988-01-31

Family

ID=25412127

Family Applications (1)

Application Number Title Priority Date Filing Date
IL83579A IL83579A0 (en) 1986-08-25 1987-08-18 Rapid acting combination of sulindac or sodium sulindac and a base

Country Status (13)

Country Link
US (1) US4704405A (no)
EP (1) EP0259990A1 (no)
JP (1) JPS6388122A (no)
KR (1) KR880002515A (no)
CN (1) CN87105828A (no)
AU (2) AU4028772A (no)
DK (1) DK440587A (no)
FI (1) FI873550A (no)
HU (1) HUT44925A (no)
IL (1) IL83579A0 (no)
NO (1) NO873562L (no)
PT (1) PT85566B (no)
ZA (1) ZA876253B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02502534A (ja) * 1987-12-18 1990-08-16 チバ‐ガイギー　アクチェンゲゼルシャフト １‐メチル‐β‐オキソ‐α‐（フェニルカルバモイル）‐２‐ピロールプロピオニトリルのトロメタミン塩
GR880100839A (el) * 1988-12-15 1994-03-31 Ciba Geigy Αλας τρομε?αμίνης του 1-με?ύλ-Β-ΟΞΟ-Α-(φαινυλοκαρβομουλό)-2-πυρρολοπροπιονιτριλίου.
KR920002148A (ko) * 1990-07-03 1992-02-28 안드레아 엘. 콜비 비스테로이드계 소염제에 의해 유발된 위장 증상을 완화시키기 위한 약제 조성물 및 이를 완화시키는 방법
US5183829A (en) * 1991-09-27 1993-02-02 Applied Analytical Industries, Inc. Oral liquid compositions of non-steroidal anti-inflammatory drugs
US5288507A (en) * 1992-07-29 1994-02-22 Merck & Co., Inc. Ibuprofen antacid combinations
CA2318128C (en) 1998-01-20 2008-10-14 Applied Analytical Industries, Inc. Oral liquid compositions
US6365180B1 (en) 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
KR100385366B1 (ko) * 2001-03-05 2003-05-27 부광약품 주식회사 생체이용율을 개선한 실리마린 제제 조성물
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
KR20030029067A (ko) * 2003-02-10 2003-04-11 정진욱 토탄과 하수종말처리장 슬라지 폐기물을 배합한 가래 탄과그 제조방법.
CA2531116A1 (en) * 2003-07-01 2005-01-20 Michael Hawley Diffusion layer modulated solids
ITMI20032523A1 (it) 2003-12-19 2005-06-20 Acraf Forma di dosaggio per uso orale comprendente un farmaco
WO2005077394A1 (en) * 2004-02-11 2005-08-25 Ramot At Tel-Aviv University Ltd Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
EP1750677B1 (en) 2004-05-28 2017-02-01 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
KR100576332B1 (ko) * 2004-07-16 2006-05-03 강승우 신규한 글라이세리드 유도체 및 이를 포함하는 통증완화용조성물
KR100621119B1 (ko) * 2005-07-28 2006-09-07 (주)삼창뉴텍 고체 화석연료의 고화 방법
EP3263117A1 (en) 2005-11-28 2018-01-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US9289409B2 (en) * 2008-04-18 2016-03-22 Warsaw Orthopedic, Inc. Sulindac formulations in a biodegradable material
US20100098746A1 (en) * 2008-10-20 2010-04-22 Warsaw Orthopedic, Inc. Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
WO2014060856A1 (en) 2012-10-16 2014-04-24 Wockhardt Limited Pharmaceutical compositions of diclofenac or salts thereof
WO2014060855A1 (en) 2012-10-16 2014-04-24 Wockhardt Limited Pharmaceutical compositions of diclofenac or salts thereof
US20150238451A1 (en) 2012-10-19 2015-08-27 Wockhardt Limited Pharmaceutical compositions of diclofenac or salts thereof
CN109223740A (zh) * 2016-12-26 2019-01-18 云南中医学院 一种氨丁三醇有机酸盐的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE134672C (no) *
US3654349A (en) * 1970-05-01 1972-04-04 Merck & Co Inc Substituted indenyl acetic acids
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
US4402979A (en) * 1980-03-21 1983-09-06 Merck & Co., Inc. & Laboratories Ophthalmic formulations of 5-fluoro-2-methyl-1-(p-methylthiobenzylidene)-3-indenylacetic acid
US4307114A (en) * 1980-06-19 1981-12-22 Ayerst, Mckenna & Harrison, Inc. Aldose reductase inhibition by (Z)-5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid

Also Published As

Publication number Publication date
NO873562D0 (no) 1987-08-24
FI873550A (fi) 1988-02-26
FI873550A0 (fi) 1987-08-17
PT85566A (en) 1987-09-01
HUT44925A (en) 1988-05-30
KR880002515A (ko) 1988-05-09
CN87105828A (zh) 1988-04-27
EP0259990A1 (en) 1988-03-16
AU4028772A (en) 1973-09-27
DK440587D0 (da) 1987-08-24
DK440587A (da) 1988-02-26
AU7715687A (en) 1988-02-25
PT85566B (en) 1989-11-09
NO873562L (no) 1988-02-26
US4704405A (en) 1987-11-03
ZA876253B (en) 1988-04-27
JPS6388122A (ja) 1988-04-19

Similar Documents

Publication Publication Date Title
IL83579A0 (en) Rapid acting combination of sulindac or sodium sulindac and a base
ZW7487A1 (en) Tetrahydronaphthaline and indane derivatives
ZW10287A1 (en) Tetrahydronaphthaline and indane derivatives
GB2188535B (en) Hand and tool support
HK1003115A1 (en) Il-1 alpha derivatives and drugs
NZ223017A (en) Piperidine derivatives and analgesics
ZA874727B (en) S-trifluorobutenyl derivatives and pesticidal uses
GB2333292B (en) Derivatives of hexaazoisowurtzitane
EP0255801A3 (en) Anilinotriazines and their use
ZA874097B (en) Certain 4-oxo-3-benzoylvalerolactones and thiolactones
GB2194240B (en) Preparation and uses of interferon-gamma
GB2190918B (en) Polyanhydride-siloxanes and polyimide-siloxanes obtained therefrom
GB2196002B (en) Preparation of polyfluoroaldehydes and polyfluoroacetals
DE3760806D1 (en) Monohalogenotrifluorooxetane and its preparation
GB2194235B (en) Dichlorotrifluoromethyltoluenes and preparation thereof
GB2190824B (en) Pendant
EP0233740A3 (en) Aerocavin and aerocyanidin - antibiotics
GR871634B (en) Therapeutic mean and its usage
GB2191482B (en) Substituted pyrimidoindoles and diazepinoindoles
GB9013841D0 (en) Use of disamycin a and derivatives thereof
ZA873504B (en) Tetrahydronaphthaline and indane derivatives
IE872259L (en) rapid absorbing and cating combination of sulindac or sodium¹sulindac and a base
AU100506S (en) Mattress base and squabs
GR860315B (en) Supports and clothes-horse of a balcony
IL92606A0 (en) Sphingenine and derivatives thereof